Kuanghui Lu

Title: Kuanghui Lu: Innovator in Peptide Compounds

Introduction

Kuanghui Lu is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that modulate fibroblast growth factor receptor activity. His work has implications for various therapeutic applications.

Latest Patents

One of Kuanghui Lu's key patents is focused on peptide compounds useful for modulating FGF receptor activity. This invention provides peptide compounds that bind to either a fibroblast growth factor (FGF) or a fibroblast growth factor receptor (FGFR), specifically FGFR2-IIIC. The peptide compound comprises an amino acid sequence: (Y/F)-(L/F/I)-(R/D/E/S/Y/G)-(Q/L/Y)-Y-(M/L/K/R)-(L/M/D/E/N/S)-(R/L/S/T)-(L/F/M/V) (SEQ ID NO: 1). The invention also includes pharmaceutical compositions containing these peptide compounds and methods for modulating FGFR activity.

Career Highlights

Kuanghui Lu is associated with Praecis Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative work has led to a patent that showcases his expertise in peptide chemistry and its applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Howard Benjamin and Ling Chai, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kuanghui Lu's contributions to the field of peptide compounds demonstrate his commitment to advancing medical science. His work not only highlights his inventive spirit but also the potential for significant therapeutic advancements.